Interestingly, the proportion of patients with CTX/Ocn ratio above the median was significantly higher in cachectic than cancer control patients (67.7 vs 28.6%, p < 0.01 and 67.9 vs 18.8%, p < 0.01 after exclusion of bone metastases). This evidence concerns the gene BGLAP and cancer.